Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Bought by Bontempo Ohly Capital Mgmt LLC

Bontempo Ohly Capital Mgmt LLC lifted its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 1.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 166,556 shares of the pharmacy operator’s stock after buying an additional 2,580 shares during the quarter. Walgreens Boots Alliance accounts for 1.0% of Bontempo Ohly Capital Mgmt LLC’s portfolio, making the stock its 27th biggest holding. Bontempo Ohly Capital Mgmt LLC’s holdings in Walgreens Boots Alliance were worth $2,014,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Capital World Investors boosted its position in Walgreens Boots Alliance by 57.5% during the first quarter. Capital World Investors now owns 29,061,021 shares of the pharmacy operator’s stock worth $630,334,000 after purchasing an additional 10,612,373 shares in the last quarter. Thompson Siegel & Walmsley LLC grew its stake in Walgreens Boots Alliance by 98.8% in the 2nd quarter. Thompson Siegel & Walmsley LLC now owns 6,021,126 shares of the pharmacy operator’s stock valued at $72,826,000 after acquiring an additional 2,992,648 shares during the last quarter. Newport Trust Company LLC acquired a new stake in Walgreens Boots Alliance in the 2nd quarter valued at about $31,028,000. Norges Bank acquired a new position in Walgreens Boots Alliance during the fourth quarter worth about $29,816,000. Finally, Swedbank AB acquired a new position in Walgreens Boots Alliance during the first quarter worth about $16,365,000. Institutional investors and hedge funds own 58.59% of the company’s stock.

Wall Street Analyst Weigh In

WBA has been the subject of several analyst reports. Morgan Stanley cut their price target on Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating for the company in a report on Friday, June 28th. Evercore ISI cut their price objective on shares of Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating on the stock in a report on Friday, June 28th. TD Cowen lowered their target price on shares of Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating for the company in a report on Thursday, September 12th. JPMorgan Chase & Co. cut their price target on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research note on Friday, August 30th. Finally, Royal Bank of Canada lowered their price objective on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a research note on Tuesday, July 2nd. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $14.73.

Check Out Our Latest Report on Walgreens Boots Alliance

Walgreens Boots Alliance Stock Up 6.3 %

NASDAQ WBA opened at $9.06 on Friday. The business has a 50 day moving average price of $10.00 and a two-hundred day moving average price of $14.28. The stock has a market cap of $7.82 billion, a PE ratio of -1.34, a P/E/G ratio of 0.97 and a beta of 0.70. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.22 and a fifty-two week high of $27.05. The company has a quick ratio of 0.31, a current ratio of 0.65 and a debt-to-equity ratio of 0.49.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last announced its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing the consensus estimate of $0.68 by ($0.05). The company had revenue of $36.40 billion for the quarter, compared to analyst estimates of $35.94 billion. Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. Walgreens Boots Alliance’s revenue was up 2.8% on a year-over-year basis. During the same period in the prior year, the business earned $1.00 earnings per share. As a group, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 2.86 EPS for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 12th. Shareholders of record on Wednesday, August 21st were paid a dividend of $0.25 per share. The ex-dividend date was Wednesday, August 21st. This represents a $1.00 annualized dividend and a yield of 11.04%. Walgreens Boots Alliance’s payout ratio is -14.84%.

Walgreens Boots Alliance Company Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Further Reading

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.